Appendiceal goblet cell carcinoids: Management considerations from a reference peritoneal tumour service centre and ENETS centre of excellence

Neuroendocrinology

Volumn 103, Issue 5, 2016, Pages 500-517

  Lamarca, Angela ^a   Nonaka, Daisuke ^a,b   Lopez Escola, Cristina ^a   Hubner, Richard A ^a   O'Dwyer, Sarah ^a   Chakrabarty, Bipasha ^a   Fulford, Paul ^a   Valle, Juan W ^a,b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cytoreductive surgery; Goblet cell carcinoid; Hyperthermic intra peritoneal chemotherapy; Pathology; Surgery; Systemic chemotherapy; Tang classification

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; IRINOTECAN; MITOMYCIN; OXALIPLATIN; KI 67 ANTIGEN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGE; AGED; APPENDECTOMY; APPENDIX CANCER; APPENDIX GOBLET CELL CARCINOID; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOID; COHORT ANALYSIS; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; GENERAL CONDITION DETERIORATION; GOBLET CELL; HEMICOLECTOMY; HIGH VOLUME HOSPITAL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SELECTION BIAS; SIDE EFFECT; SURVIVAL TIME; CARCINOID TUMOR; DISEASE MANAGEMENT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; PERITONEAL NEOPLASMS; PROGNOSIS; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; COHORT STUDIES; DISEASE MANAGEMENT; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; MIDDLE AGED; PALLIATIVE MEDICINE; PERITONEAL NEOPLASMS; PROGNOSIS; UNITED KINGDOM;

EID: 84941762888     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000440725     Document Type: Article

References (48)

1. Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7, 970 appendectomies. Dis Colon Rectum 1998; 41: 75-80.
2. McCusker ME, Cote TR, Clegg LX, et al. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer 2002; 94: 3307-3312.
3. Subbuswamy SG, Gibbs NM, Ross CF, et al. Goblet cell carcinoid of the appendix. Cancer 1974; 34: 338-344.
4. Pahlavan PS, Kanthan R. Goblet cell carcinoid of the appendix. World J Surg Oncol 2005; 3: 36.
5. Turaga KK, Pappas SG, Gamblin T. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol 2012; 19: 1379-1385.
6. Hsu C, Rashid AF, Xing YF, Chiang Y-J, et al. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype. J Surg Oncol 2013; 107: 136-143.
7. Tang LH, Shia JF, Soslow RA, et al. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol 2008; 32: 1429-1443.
8. Pham TH, Wolff B, Abraham SC, Drelichman E. Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience. Ann Surg Oncol 2006; 13: 370-376.
9. Hirschfield LS, Kahn LB, Winkler BF, et al. Adenocarcinoid of the appendix presenting as bilateral Krukenberg s tumor of the ovaries. Immunohistochemical and ultrastructural studies and literature review. Arch Pathol Lab Med 1985; 109: 930-933.
10. Yan TD, Brun EA, Sugarbaker PH. Discordant histology of primary appendiceal adenocarcinoid neoplasms with peritoneal dissemination. Ann Surg Oncol 2008; 15: 1440-1446.
11. van ES, Offerhaus GJ, Hart AA, et al. Goblet cell carcinoid of the appendix: a specific type of carcinoma. Histopathology 2007; 51: 763-773.
12. Liu E, Telem DA, Warner RR, et al. The role of Ki-67 in predicting biological behavior of goblet cell carcinoid tumor in appendix. Am J Surg 2011; 202: 400-403.
13. Toumpanakis C, Standish RA, Baishnab EF, et al. Goblet cell carcinoid tumors (adenocarcinoid) of the appendix. Dis Colon Rectum 2007; 50: 315-322.
14. Warner RR, O Dorisio TM. Radiolabeled peptides in diagnosis and tumor imaging: clinical overview. Semin Nucl Med 2002; 32: 79-83.
15. Plockinger U, Couvelard AF, Falconi MF, et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma. Neuroendocrinology 2008; 87: 20-30.
16. Mandai M, Konishi IF, Tsuruta YF, et al. Krukenberg tumor from an occult appendiceal adenocarcinoid: a case report and review of the literature. Eur J Obstet Gynecol Reprod Biol 2001; 97: 90-95.
17. Olsson BF, Ljungberg O. Adenocarcinoid of the vermiform appendix. Virchows Arch A Pathol Anat Histol 1980; 386: 201-210.
18. Heisterberg LF, Wahlin AF, Nielsen KS. Two cases of goblet cell carcinoid tumor of the appendix with bilateral ovarian metastases. Acta Obstet Gynecol Scand 1982; 61: 153-156.
19. Edmonds PF, Merino MJ, LiVolsi VA, et al. Adenocarcinoid (mucinous carcinoid) of the appendix. Gastroenterology 1984; 86: 302-309.
20. Bak MF, Jorgensen LJ. Adenocarcinoid of the appendix presenting with metastases to the liver. Dis Colon Rectum 1987; 30: 112-115.
21. Miller RT, Sarikaya HF, Jenison EL. Adenocarcinoid tumor of appendix presenting as unilateral Krukenberg tumor. J Surg Oncol 1988; 37: 65-71.
22. Ikeda E, Tsutsumi YF, Yoshida HF, et al. Goblet cell carcinoid of the vermiform appendix with ovarian metastasis mimicking mucinous cystadenocarcinoma. Acta Pathol Jpn 1991; 41: 455-460.
23. Butler JA, Houshiar AF, Lin FF, et al. Goblet cell carcinoid of the appendix. Am J Surg 1994; 168: 685-687.
24. Klein EA, Rosen MH. Bilateral Krukenberg tumors due to appendiceal mucinous carcinoid. Int J Gynecol Pathol 1996; 15: 85-88.
25. Stancu M, Wu TT, Wallace CF, et al. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod Pathol 2003; 16: 1189-1198.
26. Garin L, Corbinais SF, Boucher EF, et al. Adenocarcinoid of the appendix vermiformis: complete and persistent remission after chemotherapy (folfox) of a metastatic case. Dig Dis Sci 2002; 47: 2760-2762.
27. Pape UF, Perren AF, Niederle BF, et al. ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology 2012; 95: 135-156.
28. Park K, Blessing KF, Kerr KF, et al. Goblet cell carcinoid of the appendix. Gut 1990; 31: 322-324.
29. Warkel RL, Cooper PH, Helwig EB. Adenocarcinoid, a mucin-producing carcinoid tumor of the appendix: a study of 39 cases. Cancer 1978; 42: 2781-2793.
30. Gordon R, Burns KF, Friedlich M. Goblet cell carcinoid of the appendix. Can J Surg 2005; 48: 251-252.
31. Byrn JC, Wang JL, Divino CM, et al. Management of goblet cell carcinoid. J Surg Oncol 2006; 94: 396-402.
32. Bucher P, Gervaz PF, Ris FF, et al. Surgical treatment of appendiceal adenocarcinoid (goblet cell carcinoid). World J Surg 2005; 29: 1436-1439.
33. Murphy EM, Farquharson SM, Moran BJ. Management of an unexpected appendiceal neoplasm. Br J Surg 2006; 93: 783-792.
34. Varisco B, McAlvin BF, Dias JF, et al. Adenocarcinoid of the appendix: is right hemicolectomy necessary?. A meta-Analysis of retrospective chart reviews. Am Surg 2004; 70: 593-599.
35. Mahteme H, Sugarbaker PH. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Br J Surg 2004; 91: 1168-1173.
36. McConnell YJ, Mack LA, Gui XF, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix. Ann Surg Oncol 2014; 21: 1975-1982.
37. Cashin P, Nygren PF, Hellman PFU, et al. Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survival. Clin Colorectal Cancer 2011; 10: 108-112.
38. http://www.rtog.org/LinkClick.aspx?fileticke t=oClaTCMufRA%3D&tabid=290.
39. Edge S, et al (eds): AJCC Cancer Staging Manual Berlin, Springer 2015.
40. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE- 4.03-2010-06-14-QuickReference- 8.5x11.pdf
41. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
42. Olsen IH, et al. Goblet cell carcinoids: characteristics of a Danish Cohort of 83 patients (abstract). ESMO Conference 2014. Ann Oncol 2015; 25(suppl 4): 1151P.
43. Gouzi JL, Laigneau P, Delalande JP, et al. Indications for right hemicolectomy in carcinoid tumors of the appendix. The French Associations for Surgical Research. Surg Gynecol Obstet 1993; 176: 543-547.
44. Madani A, Van der Bilt JD, Consten EC, et al. Perforation in appendiceal well-differentiated carcinoid and goblet cell tumors: impact on prognosis?. A Systematic Review. Ann Surg Oncol 2015; 22: 959-965.
45. Rossi RE, et al. Goblet cell appendiceal tumors - management dilemmas and long-Term outcomes. Surg Oncol 2015; 24: 47-53.
46. Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; European Society for Medical Oncology (ESMO); European Society of Surgical Oncology (ESSO); European Society of Radiotherapy and Oncology (ESTRO): Gastric cancer. ESMOESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 2014; 40: 584-591.
47. de GA, Figer AF, Seymour MF, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-2947.
48. http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidencemarch-2009/.